Johns Hopkins Medicine @HopkinsMedicine · 26 Aug 2026
It is known that people prescribed the biologic adalimumab can develop treatment resistance over time. When treating eye inflammation, Wilmer researchers found escalating to weekly dosing may help prolong the medication's effectiveness. @AJOphthalmology https://t.co/815IYLoHVb https://t.co/EP00QGz6WL
3 843Views
11Likes
4Reposts
1Replies
0Quotes
0Bookmarks
Is that a lot?
0.99×vs this author's median3 899 views is typical
20Percentile for this authorof 5 recent posts
0.17×vs 100K–1M median22 159 views is typical
0.63%Reachviews ÷ followers
0.42%Engagement rateof viewers reacted